General Information |
|
Product |
EHD3 Peptide |
Description |
Antigenic Blocking Peptide EH domain-containing protein 3 Antibody |
Verified Applications |
Immunocompetition, Immunodepletion |
Peptide Description |
Synthetic peptide taken within amino acid region 475-535 on human EH-domain containing protein 3. |
Accession # |
NCBI: NP_055416.2 |
|
|
Quantity |
250 µg |
Volume |
100 µl |
Form |
Antigenic Blocking Peptide |
Storage |
-20⁰C for long term storage |
|
|
Competition/Depletion assay |
|
|
|
Uniprot # |
|
Overview |
Plays a role in endocytic transport |
Molecular Function |
ATP binding;GTPase activity;nucleic acid binding;calcium ion binding;GTP binding |
Subcellular Location |
Cell membrane, Cytoplasm, Endosome, Membrane |
Expression |
Highly expressed in heart and brain and moderately expressed in kidney, liver, and placenta. |
Structure |
Homooligomer, and heterooligomer with EHD1, EHD2 and EHD4 |
Alternative Nomenclature |
EH domain containing 3 antibody EHD2 antibody EHD3 antibody PAST3 antibody |
Protein information supplied by UniProt
Product | Note | Status | Price | |
---|---|---|---|---|
|
EHD3-301AP | |||
|
EHD3-FITC | |||
|
EHD3-BIOTIN | |||
|
PC-EHD3 | |||
Display accessory details |
Select your currency:
(c) FabGennix International Inc.